Point72 Hong Kong LTD Seagen Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $1.86 Million - $2.48 Million	13,785 New	13,785 $1.89 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $737,515 - $973,303	-6,166 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $879,086 - $1.18 Million	6,166 New	6,166 $953,000
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $738,617 - $880,894	-5,468 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $406,342 - $563,814	2,955 Added 117.59%	5,468 $759,000

Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $413,715 - $532,580	2,513 New	2,513 $440,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.